Vanguri, Rami S.
Luo, Jia http://orcid.org/0000-0003-3606-827X
Aukerman, Andrew T. http://orcid.org/0000-0003-1944-769X
Egger, Jacklynn V.
Fong, Christopher J.
Horvat, Natally
Pagano, Andrew
Araujo-Filho, Jose de Arimateia Batista
Geneslaw, Luke
Rizvi, Hira
Sosa, Ramon
Boehm, Kevin M. http://orcid.org/0000-0003-2426-5436
Yang, Soo-Ryum
Bodd, Francis M.
Ventura, Katia
Hollmann, Travis J. http://orcid.org/0000-0003-1599-0433
Ginsberg, Michelle S.
Gao, Jianjiong
Vanguri, Rami
Hellmann, Matthew D.
Sauter, Jennifer L. http://orcid.org/0000-0001-6987-2294
Shah, Sohrab P. http://orcid.org/0000-0001-6402-523X
,
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748, F30CA257414, P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748, P30CA008748)
Cycle for Survival
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (T32GM007739)
Grayer Fellowship (MSKCC), Cycle for Survival
Susan G. Komen Scholars Program, Cycle for Survival
Article History
Received: 6 January 2022
Accepted: 29 June 2022
First Online: 29 August 2022
Competing interests
: J.L. has received honoraria from Targeted Oncology and Physicians’ Education Resource. M.D.H. as of November 2021, is an employee of AstraZeneca; has grants from BMS; and personal fees from Achilles; Adagene; Adicet; Arcus; AstraZeneca; Blueprint; BMS; DaVolterra; Eli Lilly; Genentech/Roche; Genzyme/Sanofi; Janssen; Immunai; Instil Bio; Mana Therapeutics; Merck; Mirati; Natera; Pact Pharma; Shattuck Labs; and Regeneron; as well as equity options from Factorial, Immunai, Shattuck Labs and Arcus. A patent filed by MSK related to the use of TMB to predict response to immunotherapy (PCT/US2015/062208) is pending and licensed by PGDx. T.J.H. receives funding from Bristol Myers Squibb and Calico labs. M.S.G. is a consultant for Ultimate Opinions in Medicine. J.L.S. reports stock ownership in Pfizer, Thermo Fisher Scientific, Merck & Co. and Chemed Corp. S.P.S. is a shareholder and consultant for Imagia Canexia Health. The remaining authors declare no competing interests.